{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:25:43Z","timestamp":1790767543541,"version":"4.1.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302985"],"award-info":[{"award-number":["81302985"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Clinical studies have demonstrated the anti-psoriatic effect of the LiangXueJieDu (LXJD) herbal formula. However, the systemic mechanism and the targets of the LXJD formula have not yet been elucidated. In the present study, a systems pharmacology approach, metabolomics, and experimental evaluation were employed. First, by systematic absorption-distribution-metabolism-excretion (ADME) analysis, 144 active compounds with satisfactory pharmacokinetic properties were identified from 12 herbs of LXJD formula using the TCMSP database. These active compounds could be linked to 125 target proteins involved in the pathological processes underlying psoriasis. Then, the networks constituting the active compounds, targets, and diseases were constructed to decipher the pharmacological actions of this formula, indicating its curative effects in psoriasis treatment and related complications. The psoriasis-related pathway comprising several regulatory modules demonstrated the synergistic mechanisms of LXJD formula. Furthermore, the therapeutic effect of LXJD formula was validated in a psoriasis-like mouse model. Consistent with the systems pharmacology analysis, LXJD formula ameliorated IMQ-induced psoriasis-like lesions in mice, inhibited keratinocyte proliferation, improved keratinocyte differentiation, and suppressed the infiltration of CD3+ T cells. Compared to the model group, LXJD formula treatment remarkably reduced the expression of inflammatory cytokines and factors, such as IL-1\u03b2, IL-6, TNF-\u03b1, Cox2, and inhibited the phosphorylation of p-P65, p-I\u049bB, p-ERK, p-P38, p-PI3K, p-AKT, indicating that LXJD formula exerts its therapeutic effect by inhibiting the MAPK, PI3K\/AKT, and NF-\u049bB signaling pathways. The metabolic changes in the serum of psoriasis patients were evaluated by liquid chromatography coupled with orbitrap mass spectrometry (LC-MS). The LXJD formula improved two perturbed metabolic pathways of glycerophospholipid metabolism and steroid hormone biosynthesis. Overall, this study revealed the complicated anti-psoriatic mechanism of LXJD formula and also offered a reliable strategy to elucidate the complex therapeutic mechanism of this Chinese herbal formula in psoriasis from a holistic perspective.<\/jats:p>","DOI":"10.3389\/fphar.2021.626267","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T05:58:05Z","timestamp":1623131885000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Systems Pharmacology Approach and Experiment Evaluation Reveal Multidimensional Treatment Strategy of LiangXueJieDu Formula for Psoriasis"],"prefix":"10.3389","volume":"12","author":[{"given":"Jingxia","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"B4","doi-asserted-by":"publisher","first-page":"577430","DOI":"10.1016\/j.jneuroim.2020.577430","article-title":"Upregulation of Interleukin (IL)-31, a Cytokine Producing CXCR1 Peripheral Immune Cells, Contributes to the Immune Abnormalities of Autism Spectrum Disorder","volume":"349","author":"Ahmad","year":"2020","journal-title":"J. Neuroimmunology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molimm.2016.12.019","article-title":"Imbalance between the Anti- and Pro-inflammatory Milieu in Blood Leukocytes of Autistic Children","volume":"82","author":"Ahmad","year":"2017","journal-title":"Mol. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1007\/s12035-016-9977-0","article-title":"Dysregulation of Th1, Th2, Th17, and T Regulatory Cell-Related Transcription Factor Signaling in Children with Autism","volume":"54","author":"Ahmad","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"173088","DOI":"10.1016\/j.ejphar.2020.173088","article-title":"Therapeutic Treatment with Ibrutinib Attenuates Imiquimod-Induced Psoriasis-like Inflammation in Mice through Downregulation of Oxidative and Inflammatory Mediators in Neutrophils and Dendritic Cells","volume":"877","author":"Al-Harbi","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/children8020116","article-title":"Dysregulation of Ki-67 Expression in T Cells of Children with Autism Spectrum Disorder","volume":"8","author":"Alhosaini","year":"2021","journal-title":"Children"},{"key":"B7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.biopha.2018.12.060","article-title":"Inhibition of Spleen Tyrosine Kinase Attenuates Psoriasis-like Inflammation in Mice through Blockade of Dendritic Cell-Th17 Inflammation axis","volume":"111","author":"Alzahrani","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"109395","DOI":"10.1016\/j.cellsig.2019.109395","article-title":"CXCR3 Antagonist AMG487 Suppresses Rheumatoid Arthritis Pathogenesis and Progression by Shifting the Th17\/Treg Cell Balance","volume":"64","author":"Bakheet","year":"2019","journal-title":"Cell Signal."},{"key":"B9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000073094","article-title":"Complementary Medicine and Psoriasis: Linking the Patient's Outlook with Evidence-Based Medicine","volume":"207","author":"Ben-Arye","year":"2003","journal-title":"Dermatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.intimp.2017.04.022","article-title":"Quercetin Ameliorates Imiquimod-Induced Psoriasis-like Skin Inflammation in Mice via the NF-\u039ab Pathway","volume":"48","author":"Chen","year":"2017","journal-title":"Int. Immunopharmacology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/s0006-2952(03)00463-5","article-title":"Effects of Wogonin, a Plant Flavone from Scutellaria Radix, on Skin Inflammation: In Vivo Regulation of Inflammation-Associated Gene Expression","volume":"66","author":"Chi","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.12788\/j.sder.2018.039","article-title":"TNF Inhibitors for Psoriasis","volume":"37","author":"Chima","year":"2018","journal-title":"Sem Cutan. Med. Surg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.2174\/1381612826666200311130133","article-title":"Decoding Psoriasis: Integrated Bioinformatics Approach to Understand Hub Genes and Involved Pathways","volume":"26","author":"Choudhary","year":"2020","journal-title":"Cpd"},{"key":"B14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/dth.12139","article-title":"Complementary and Alternative Medicine Use Among Patients with Psoriasis","volume":"27","author":"Damevska","year":"2014","journal-title":"Dermatol. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"35037","DOI":"10.1038\/srep35037","article-title":"Comprehensive Plasma Metabolomic Analyses of Atherosclerotic Progression Reveal Alterations in Glycerophospholipid and Sphingolipid Metabolism in Apolipoprotein E-Deficient Mice","volume":"6","author":"Dang","year":"2016","journal-title":"Sci. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1039\/c3fo60441a","article-title":"Anti-proliferative Effects of Quercetin and Catechin Metabolites","volume":"5","author":"Delgado","year":"2014","journal-title":"Food Funct."},{"key":"B17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jep.2018.05.038","article-title":"Antipsoriatic Effect of Fatty Acid Enriched Fraction of Vernonia Anthelmintica Willd. Fruits","volume":"224","author":"Dogra","year":"2018","journal-title":"J. Ethnopharmacology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/archderm.136.5.609","article-title":"Troglitazone Improves Psoriasis and Normalizes Models of Proliferative Skin Disease: Ligands for Peroxisome Proliferator-Activated Receptor-Gamma Inhibit Keratinocyte Proliferation","volume":"136","author":"Ellis","year":"2000","journal-title":"Arch. Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jamadermatol.2018.2972","article-title":"Complementary and Alternative Medicine Therapies for Psoriasis","volume":"154","author":"Gamret","year":"2018","journal-title":"JAMA Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1046\/j.1523-1747.1999.00743.x","article-title":"Fetal Epidermal Differentiation and Barrier Development In Vivo Is Accelerated by Nuclear Hormone Receptor Activators1","volume":"113","author":"Hanley","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1046\/j.1365-2133.2000.03767.x","article-title":"Drug\u2010induced Suppression of Phosphorylase Kinase Activity Correlates with Resolution of Psoriasis as Assessed by Clinical, Histological and Immunohistochemical Parameters","volume":"143","author":"Heng","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1055\/a-0622-8242","article-title":"Baicalin Ameliorates Imiquimod-Induced Psoriasis-like Inflammation in Mice","volume":"84","author":"Hung","year":"2018","journal-title":"Planta Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s40263-014-0158-2","article-title":"PPAR-\u03b3 Agonism as a Modulator of Mood: Proof-Of-Concept for Pioglitazone in Bipolar Depression","volume":"28","author":"Kemp","year":"2014","journal-title":"CNS Drugs"},{"key":"B24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jaad.2007.12.035","article-title":"Oral Curcumin in the Treatment of Moderate to Severe Psoriasis Vulgaris: a Prospective Clinical Trial","volume":"58","author":"Kurd","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1210\/en.2003-0288","article-title":"Minireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated Receptors","volume":"144","author":"Lee","year":"2003","journal-title":"Endocrinology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e43918","DOI":"10.1371\/journal.pone.0043918","article-title":"A System-Level Investigation into the Mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for Cardiovascular Disease Treatment","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1590\/abd1806-4841.20132653","article-title":"Peroxisome Proliferator-Activated Receptor Agonists (PPARs): a Promising prospect in the Treatment of Psoriasis and Psoriatic Arthritis","volume":"88","author":"Lima","year":"2013","journal-title":"Bras. Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","article-title":"Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"19809","DOI":"10.1038\/srep19809","article-title":"Systems-Pharmacology Dissection of Traditional Chinese Medicine Compound Saffron Formula Reveals Multi-Scale Treatment Strategy for Cardiovascular Diseases","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"8194804","DOI":"10.1155\/2019\/8194804","article-title":"Systems Pharmacology and Microbiome Dissection of Shen Ling Bai Zhu San Reveal Multiscale Treatment Strategy for IBD","volume":"2019","author":"Lv","year":"2019","journal-title":"Oxid Med. Cel Longev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.foodchem.2013.01.030","article-title":"Anti-inflammatory and Anticancer Activities of Extracts and Compounds from the Mushroom Inonotus Obliquus","volume":"139","author":"Ma","year":"2013","journal-title":"Food Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3892\/ijmm.2017.2930","article-title":"Paeonol Ameliorates Imiquimod-Induced Psoriasis-like Skin Lesions in BALB\/c Mice by Inhibiting the Maturation and Activation of Dendritic Cells","volume":"39","author":"Meng","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.fitote.2015.08.007","article-title":"Anti-inflammatory Tirucallane Triterpenoids from Anopyxis Klaineana Pierre (Engl.), (Rhizophoraceae)","volume":"106","author":"Mireku","year":"2015","journal-title":"Fitoterapia"},{"key":"B34","doi-asserted-by":"publisher","first-page":"106215","DOI":"10.1016\/j.intimp.2020.106215","article-title":"Bruton's Tyrosine Kinase Inhibitor Suppresses Imiquimod-Induced Psoriasis-like Inflammation in Mice through Regulation of IL-23\/IL-17A in Innate Immune Cells","volume":"80","author":"Nadeem","year":"2020","journal-title":"Int. Immunopharmacology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1001\/archderm.134.10.1304","article-title":"Treatment of Psoriasis with Troglitazone Therapy","volume":"134","author":"Pershadsingh","year":"1998","journal-title":"Arch. Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1159\/000255614","article-title":"The Influence of Sitosterol upon Psoriasis Vulgaris","volume":"117","author":"Reiss","year":"1958","journal-title":"Dermatology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a Database of Systems Pharmacology for Drug Discovery from Herbal Medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. Cheminform"},{"key":"B38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/0973-7847.125528","article-title":"A Review on Phytochemical, Pharmacological, and Pharmacognostical Profile of Wrightia Tinctoria: Adulterant of Kurchi","volume":"8","author":"Srivastava","year":"2014","journal-title":"Phcog Rev."},{"key":"B39","first-page":"296","article-title":"\"Efficacy and Safety of Liangxue Jiedu Decoction for the Treatment of Progressive Psoriasis Vulgaris: a Multicenter, Randomized, Controlled Study\"","volume":"40","author":"Sun","year":"2020","journal-title":"J. Tradit Chin. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40257-015-0128-6","article-title":"Complementary and Alternative Medicine for Psoriasis: what the Dermatologist Needs to Know","volume":"16","author":"Talbott","year":"2015","journal-title":"Am. J. Clin. Dermatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/cbin.10740","article-title":"Untargeted Metabolomics Analysis of Adipogenic Transformation in OP9-DL1 Cells Using Liquid Chromatography-Mass Spectrometry: Implications for Thymic Adipogenesis","volume":"41","author":"Tan","year":"2017","journal-title":"Cell Biol Int"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1002\/jps.20217","article-title":"Application of ALOGPS to Predict 1\u2010octanol\/water Distribution Coefficients, logP, and logD, of AstraZeneca In\u2010house Database","volume":"93","author":"Tetko","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fmolb.2019.00120","article-title":"Targeted Metabolomic Analysis of Serum Fatty Acids for the Prediction of Autoimmune Diseases","volume":"6","author":"Tsoukalas","year":"2019","journal-title":"Front. Mol. Biosci."},{"key":"B1","first-page":"7","volume-title":"Global Report on Psoriasis","year":"2016"},{"key":"B44","doi-asserted-by":"publisher","first-page":"E1060","DOI":"10.1210\/jc.2012-4132","article-title":"Metabolic Signature Shift in Type 2 Diabetes Mellitus Revealed by Mass Spectrometry-Based Metabolomics","volume":"98","author":"Xu","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.2147\/IJN.S75550","article-title":"Enhancing the Anti-colon Cancer Activity of Quercetin by Self-Assembled Micelles","volume":"10","author":"Xu","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"B46","first-page":"358","article-title":"Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor-3 and Cyclooxygenase-2 Expression in Psoriasis","volume":"29","author":"Yal\u00e7in","year":"2007","journal-title":"Anal. Quant Cytol. Histol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fphar.2020.00284","article-title":"An Integrated Pharmacology-Based Analysis for Antidepressant Mechanism of Chinese Herbal Formula Xiao-Yao-San","volume":"11","author":"Yuan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gigascience\/gix087","article-title":"Lipidomics Profiling Reveals the Role of Glycerophospholipid Metabolism in Psoriasis","volume":"6","author":"Zeng","year":"2017","journal-title":"Gigascience"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.3892\/mmr.2016.4999","article-title":"PageRank Analysis Reveals Topologically Expressed Genes Correspond to Psoriasis and Their Functions Are Associated with Apoptosis Resistance","volume":"13","author":"Zeng","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/s0254-6272(09)60064-9","article-title":"Distribution and Development of the TCM Syndromes in Psoriasis Vulgaris","volume":"29","author":"Zhang","year":"2009","journal-title":"J. Traditional Chin. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejphar.2015.12.040","article-title":"Paeoniflorin Inhibits Imiquimod-Induced Psoriasis in Mice by Regulating Th17 Cell Response and Cytokine Secretion","volume":"772","author":"Zhao","year":"2016","journal-title":"Eur. J. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.626267\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T05:58:11Z","timestamp":1623131891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.626267\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":51,"alternative-id":["10.3389\/fphar.2021.626267"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.626267","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]},"article-number":"626267"}}